Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by Cavailles
Group name EquipeVC
Item Type Journal Article
Title Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer
Creator Vattai et al.
Author Aurelia Vattai
Author Sophie Sixou
Author Susanne Beyer
Author Christina Kuhn
Author Mina Peryanova
Author Helene Heidegger
Author Kerstin Hermelink
Author Doris Mayr
Author Sven Mahner
Author Christian Dannecker
Author Udo Jeschke
Author Bernd Kost
Abstract Introduction: RIP140 (Receptor Interacting Protein) is involved in the regulation of oncogenic signaling pathways and in the development of breast and colon cancers. The aim of the study was to analyze the expression of RIP140 and its partner LCoR in cervical cancers, to decipher their relationship with histone protein modifications and to identify a potential link with patient survival. Methods: Immunohistochemical analyses were carried out to quantify RIP140 and LCoR expression in formalin-fixed paraffin-embedded tissue sections cervical cancer samples. Correlations of RIP140 and LCoR expression with histopathological variables were determined by correlation analyses. Survival rates of patients expressing low or high levels of RIP140 and LCoR were compared by Kaplan-Meier curves. Results: RIP140 overexpression was associated with a significantly shorter overall survival of cervical cancer patients. This effect was significant in the squamous cell carcinoma subtype but not in adenocarcinomas. RIP140 is no longer a significant negative prognosticator for cervical cancer when LCoR expression is low. Discussion: RIP140 is an independent predictor of poor survival of patients with cervical cancer. Patients with tumors expressing low levels of both RIP140 and LCoR showed a better survival compared to patients expressing high levels of RIP140. Modulation of RIP140 and LCoR may represent a novel targeting strategy for cervical cancer prevention and therapy.
Publication Oncotarget
Volume 8
Issue 62
Pages 105356-105371
Date Dec 01, 2017
Journal Abbr Oncotarget
Language eng
DOI 10.18632/oncotarget.22187
ISSN 1949-2553
Library Catalog PubMed
Extra PMID: 29285256 PMCID: PMC5739643
Tags cervical carcinoma, LCoR, original, RIP140/NRIP1, squamous cell carcinoma
Date Added 2019/05/16 - 11:22:17
Date Modified 2019/05/16 - 11:41:21
Notes and Attachments PubMed entry (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés